Actualités
A large animal model of Spinal Muscular Atrophy and correction of phenotype.
Duque SI, Arnold WD, Odermatt P, Li X, Porensky PN, Schmelzer L, Meyer K, Kolb SJ, Schümperli D, Kaspar BK, Burghes AH. Ann Neurol. 2014 Dec 16.
16 décembre 2014
Raptor ablation in skeletal muscle decreases Cav1.1 expression and affects the function of the excitation-contraction coupling supramolecular complex.
Lopez RJ, Mosca B, Treves S, Maj M, Bergamelli L, Calderon JC, Bentzinger CF, Romanino K, Hall MN, Rüegg MA, Delbono O, Caputo C, Zorzato F. Biochem J. 2014 Nov 28.
28 novembre 2014
ENMC Workshop report: SMA outcomes and clinical trial readiness
Richard Finkel, Enrico Bertini, Francesco Muntoni and Eugenio Mercuri 7-9 November 2014, Heemsklerk, The Netherland
18 novembre 2014
Inositol 1,4,5 trisphosphate receptor 1 is a key player of human myoblast differentiation.
Antigny F, Konig S, Bernheim L, Frieden M. Cell Calcium. 2014 Nov 4;56(6):513-521.
04 novembre 2014
The FgfrL1 receptor is required for development of slow muscle fibers.
Amann R, Wyder S, Slavotinek AM, Trueb B. Dev Biol. 2014 Oct 15;394(2):228-41.
15 octobre 2014
The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy.
Voigt T, Neve A, Schümperli D. Neuropathol Appl Neurobiol. 2014 Jun;40(4):416-34
19 septembre 2014
A PiggyBac-mediated approach for muscle gene transfer or cell therapy.
Ley D, Van Zwieten R, Puttini S, Iyer P, Cochard A, Mermod N. Stem Cell Res. 2014 Sep 8;13(3PA):390-403.
08 septembre 2014
The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet.
Pérez-Schindler J, Svensson K, Vargas-Fernández E, Santos G, Wahli W, Handschin C. Diabetologia. 2014 Aug 13.
25 août 2014
Santhera Repositions Omigapil in Congenital Muscular Dystrophy and Initiates Clinical Development Program with Public-Private Partners
17 juillet 2014
Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy.
van Zwieten RW, Puttini S, Lekka M, Witz G, Gicquel-Zouida E, Richard I, Lobrinus JA, Chevalley F, Brune H, Dietler G, Kulik A, Kuntzer T, Mermod N. Nanomedicine...
12 juin 2014
FSRMM
- Chemin des Saules 4B
2013 Colombier - +41 78 629 63 92
- philippe.rognon@fsrmm.ch